Article
Radiology, Nuclear Medicine & Medical Imaging
Sang Woo Lee, Seong-Jang Kim
Summary: The systematic review and meta-analysis showed that F-18-FDG PET/CT has good diagnostic performance in detecting lymph node metastasis in penile cancer patients, with similar accuracy in detecting inguinal and pelvic lymph node metastasis.
CLINICAL NUCLEAR MEDICINE
(2022)
Article
Radiology, Nuclear Medicine & Medical Imaging
Gary A. Ulaner, Komal Jhaveri, Sarat Chandarlapaty, Vaios Hatzoglou, Christopher C. Riedl, Jason S. Lewis, Audrey Mauguen
Summary: For patients with invasive lobular carcinoma (ILC), F-18-FES PET/CT shows comparable detection of metastases to F-18-FDG PET/CT. In a study, it was found that F-18-FES PET/CT may be more effective at detecting metastatic lesions in ILC patients compared to F-18-FDG PET/CT.
JOURNAL OF NUCLEAR MEDICINE
(2021)
Editorial Material
Radiology, Nuclear Medicine & Medical Imaging
Jin Qi, Elizabeth Kurian, Orhan K. oez
Summary: Hibernomas are rare benign tumors originating from fetal brown adipose tissue. They can occur in various parts of the body, with thigh, shoulder, back, and neck being the most common locations, and are rarely found in the abdominal cavity, retroperitoneum, breast, bones, scrotum, and perirectum. We present a case of a 58-year-old woman with a mediastinal mass, who was incidentally found to have an FDG-avid fat-containing lesion in the omentum abutting the stomach.
CLINICAL NUCLEAR MEDICINE
(2023)
Article
Oncology
Janna Morawitz, Nils-Martin Bruckmann, Kai Jannusch, Frederic Dietzel, Aleksandar Milosevic, Ann-Kathrin Bittner, Oliver Hoffmann, Svjetlana Mohrmann, Eugen Ruckhaeberle, Lena Haeberle, Wolfgang Peter Fendler, Ken Herrmann, Frederik Lars Giesel, Gerald Antoch, Lale Umutlu, Bernd Kowall, Andreas Stang, Julian Kirchner
Summary: F-18-FDG PET/MRI is superior to conventional imaging and MRI in nodal staging in patients with newly diagnosed breast cancer. It accurately detects nodal positive status and classifies it into the correct clinical lymph node stage more often. F-18-FDG PET/MRI has the potential to be an alternative to invasive staging procedures for assessing the N stage.
Review
Radiology, Nuclear Medicine & Medical Imaging
Sangwon Han, Joon Young Choi
Summary: The systematic review and meta-analysis found that the use of F-18-FDG PET, PET/CT, or PET/MRI during the initial staging of breast cancer can significantly modify staging and treatment plans for patients. Factors such as age, initial stage, and histologic grade were identified as significant factors affecting the heterogeneity in changes in stage or management. Routine clinical use of PET imaging for initial staging of breast cancer may be beneficial based on current literature.
CLINICAL NUCLEAR MEDICINE
(2021)
Article
Medicine, General & Internal
Lara Nassar, Mutaz Kassas, Alain S. Abi-Ghanem, Malak El-Jebai, Safaa Al-Zakleet, Amro S. Baassiri, Rami Abou Naccoul, Andrew Barakat, Arafat Tfayli, Hazem Assi, Ghina Berjawi, Enrique Estrada-Lobato, Francesco Giammarile, Sobhan Vinjamuri, Mohamad Haidar
Summary: Prone FDG PET/CT acquisition is more effective than supine acquisition in detecting primary breast lesions and metastatic lymph nodes in breast cancer patients. It showed higher sensitivity and specificity in detecting breast tumor lesions and FDG-avid axillary lymph nodes. The prone position also had significantly higher detection rate and SUVmax for axillary lymph nodes. This technique has the potential to change patient staging and management.
Article
Radiology, Nuclear Medicine & Medical Imaging
Halil Komek, Canan Can, Ihsan Kaplan, Cihan Gundogan, Ferat Kepenek, Huseyin Karaoglan, Aykut Demirkiran, Senar Ebinc, Yunus Guzel, Ebubekir Gundes
Summary: [(68) Ga]Ga-DOTA-FAPI-04 PET/CT demonstrates higher sensitivity and specificity in the evaluation of primary lesions and metastases in patients with colorectal cancer.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
(2022)
Article
Oncology
Dan Cohen, Chava Perry, Shir Hazut-Krauthammer, Mikhail Kesler, Yair Herishanu, Efrat Luttwak, Einat Even-Sapir, Irit Avivi
Summary: This paper summarizes the experience in assessing the extent and metabolic characteristics of MALT lymphomas using [F-18]FDG PET-CT. It reveals that PET-CT has a high detection rate for extranodal lesions located in tissues with low/homogeneous physiologic [F-18]FDG uptake, and increased [F-18]FDG uptake in extranodal lesions predicts worse disease progression.
Article
Radiology, Nuclear Medicine & Medical Imaging
Sang Woo Lee, Seong-Jang Kim
Summary: This study evaluated the diagnostic accuracies of dual-time-point F-18-FDG PET/CT for detecting metastatic mediastinal lymph nodes in NSCLC patients. Results showed that dual-time-point F-18-FDG PET/CT exhibited good diagnostic performances for detecting metastatic mediastinal LNs, with retention index or %Delta SUVmax being superior to early or delayed images for detection of mediastinal LN metastasis.
CLINICAL NUCLEAR MEDICINE
(2022)
Article
Oncology
Clement Bouron, Clara Mathie, Valerie Seegers, Olivier Morel, Pascal Jezequel, Hamza Lasla, Camille Guillerminet, Sylvie Girault, Marie Lacombe, Avigaelle Sher, Franck Lacoeuille, Anne Patsouris, Aude Testard
Summary: The aim of this study was to evaluate PET/CT parameters for determining different prognostic groups in triple-negative breast cancer (TNBC). The study found that MTV, TLG, and entropy could be of interest in predicting the prognostic outcome of TNBC patients. Textural features associated with metabolic and volumetric parameters of baseline [F-18]FDG PET/CT have a prognostic value for identifying high-relapse-risk groups in early TNBC patients.
Editorial Material
Radiology, Nuclear Medicine & Medical Imaging
Caner Civan, Duygu Has Simsek, Emine Goknur Isik, Yasemin Sanli, Serkan Kuyumcu
Summary: A 69-year-old woman with breast cancer had F-18-FDG PET/CT and Ga-68-FAPI-04 PET/CT for evaluation. F-18-FDG PET/CT showed hypermetabolic lymph nodes, while Ga-68-FAPI-04 PET/CT showed negative results for these nodes. Biopsy confirmed metastasis of breast cancer. This case highlights the possibility of false-negative Ga-68-FAPI-04 PET/CT findings in evaluating metastatic spread in breast cancer.
CLINICAL NUCLEAR MEDICINE
(2023)
Editorial Material
Radiology, Nuclear Medicine & Medical Imaging
Victor Fernandes Vieira, Estelle Dubruc, Wassim Raffoul, John O. Prior, Marie Meyer
Summary: A 45-year-old woman with a history of breast cancer underwent breast reconstruction surgery with silicone implant, and several years later, PET/CT scan revealed F-18-FDG-avid nodules in the area of the implant, in the right internal mammary chain, and in the contralateral breast. Biopsies confirmed the presence of silicone granulomas in both breasts, without any signs of malignancy. This case highlights the intense F-18-FDG uptake in silicone granulomas affecting the contralateral breast after implant reconstruction.
CLINICAL NUCLEAR MEDICINE
(2021)
Article
Oncology
Suk-Hyun Lee, Jee-Soo Park, Hyunjeong Kim, Dongwoo Kim, Seung-Hwan Lee, Won-Sik Ham, Woong-Kyu Han, Young-Deuk Choi, Mijin Yun
Summary: The heterogeneous uptake of both F-18 FDG and C-11 methionine on PET/CT in renal cell carcinomas is associated with higher grades of cancer. The metabolic tumour volume on F-18 FDG PET/CT but not C-11 methionine PET/CT is significant in predicting advanced-stage renal cell carcinoma. These metabolic features derived from PET/CT imaging may aid in the development of new drugs targeting glucose and amino acid metabolic pathways.
Article
Radiology, Nuclear Medicine & Medical Imaging
Jie Ding, Jiangdong Qiu, Zhixin Hao, Hua Huang, Qiaofei Liu, Wenjing Liu, Chao Ren, Marcus Hacker, Taiping Zhang, Wenming Wu, Xiang Li, Li Huo
Summary: This study evaluated the performance of [(68) Ga]Ga-FAPI-04 and [F-18]F-FDG PET/CT on the disease staging and prognostic value of patients with localized PDAC. The results showed that [(68) Ga]Ga-FAPI-04 was more sensitive and accurate than [F-18]F-FDG, and could be used for staging and prognostic evaluation of PDAC, providing a non-invasive guide for clinical management.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
(2023)
Article
Oncology
Lidija Antunovic, Alessia Artesani, Alessandro Vigano, Arturo Chiti, Armando Santoro, Martina Sollini, Silvia D. Morbelli, Rita De Sanctis
Summary: This study aimed to examine brain metabolic patterns on [F-18]Fluorodeoxyglucose ([F-18]FDG) positron emission tomography (PET) in breast cancer (BC), comparing patients with tension-type headache (TTH), migraine (MiG), and those without headache. The results showed that headache patients exhibited hypometabolism in specific brain regions before neoadjuvant chemotherapy (NAC) and headache patients with a good response to NAC showed hypermetabolic brain regions in the anterior medial frontal cortex.
Article
Oncology
Mark Jesus M. Magbanua, Laura H. Hendrix, Terry Hyslop, William T. Barry, Eric P. Winer, Clifford Hudis, Deborah Toppmeyer, Lisa Anne Carey, Ann H. Partridge, Jean-Yves Pierga, Tanja Fehm, Jose Vidal-Martinez, Dimitrios Mavroudis, Jose A. Garcia-Saenz, Justin Stebbing, Paola Gazzaniga, Luis Manso, Rita Zamarchi, Maria Luisa Antelo, Leticia De Mattos-Arruda, Daniele Generali, Carlos Caldas, Elisabetta Munzone, Luc Dirix, Amy L. Delson, Harold J. Burstein, Misbah Qadir, Cynthia Ma, Janet H. Scott, Francois-Clement Bidard, John W. Park, Hope S. Rugo
Summary: This study identified 4 novel prognostic groups in metastatic breast cancer (MBC) based on similarities in circulating tumor cell (CTC) trajectory patterns during chemotherapy. Patients with intermediate+high CTCs (19.4%) had significantly poorer outcomes and may benefit from more effective treatment. This novel prognostic classification approach may guide future prospective clinical trials in MBC.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
(2021)
Article
Radiology, Nuclear Medicine & Medical Imaging
Julian Kirchner, Joseph A. O'Donoghue, Anton S. Becker, Gary A. Ulaner
Summary: The Bayesian penalized likelihood reconstruction algorithm Q.Clear improved the quality of Zr-89-immunoPET images, offering potential for future studies to enhance image quality and/or decrease the administered activity of Zr-89-immunoPET tracers.
Article
Oncology
Deaglan McHugh, Scott Tagawa, Natalie Moryl, Matthew Milowsky, Glenn Heller, Joseph Osborne, Dana Rathkopf, Ethan Basch, Neeta Pandit-Taskar, Michael J. Morris
Summary: This multicenter phase II trial prospectively examined the pain palliation of Radium-223 in mCRPC patients using standard dosing and contemporary endpoints. While the pain response rate easily exceeded the requirements for expansion to the second phase, slow accrual led to the trial being closed.
CLINICAL GENITOURINARY CANCER
(2021)
Retraction
Oncology
Kotha Subbaramaiah, Patrick G. Morris, Xi Kathy Zhou, Monica Morrow, Baoheng Du, Dilip Giri, Levy Kopelovich, Clifford A. Hudis, Andrew J. Dannenberg
Review
Radiology, Nuclear Medicine & Medical Imaging
Gary A. Ulaner
Summary: Estrogen receptor (ER) is highly expressed in 70%-80% of breast cancers and plays a central role in prognosis and treatment selection. The gold standard for determining ER status has been pathology, but it has limitations in providing spatial and temporal information and determining ER functionality. 16a-18F-fluoro-17b-Fluoroestradiol (FES) is a radiolabeled form of estrogen that allows non-invasive evaluation of functional ER. FES has shown correlation with ER immunohistochemistry, detection of ER heterogeneity, and high diagnostic accuracy for ER-positive tumors.
SEMINARS IN NUCLEAR MEDICINE
(2022)
Article
Radiology, Nuclear Medicine & Medical Imaging
Gary A. Ulaner, Beth Thomsen, Jeffrey Bassett, Robert Torrey, Craig Cox, Kevin Lin, Trushar Patel, Tust Techasith, Audrey Mauguen, Steven P. Rowe, Liza Lindenberg, Esther Mena, Peter Choyke, Jeffrey Yoshida
Summary: The positive predictive value (PPV) of DCFPyL PET/CT was evaluated for suspected distant metastases and recurrence sites in newly diagnosed high-risk and biochemically recurrent (BCR) prostate cancer. The results showed a PPV of 74% in newly diagnosed prostate cancer and 89% in BCR prostate cancer. However, false-positive findings in ribs and pelvic bones should be considered.
Article
Oncology
Juana Martinez, Kritika Subramanian, Sandra Huicochea Castellanos, Charlene Thomas, Arindam Roy Choudhury, Brett Muench, Scott T. Tagawa, Naga Vara Kishore Pillarsetty, Joseph R. Osborne
Summary: This study evaluates the equivalence between two manufacturing processes for 68Ga-PSMA: 68Ga-PSMA-cyclotron and 68Ga-PSMA-generator. The results suggest that both methods yield similar results in detecting PSMA+ lesions, indicating the potential of cyclotron-produced 68Ga-PSMA for large-scale production, cost reduction, and increased availability of the radioisotope for future use.
TRANSLATIONAL ONCOLOGY
(2023)
Editorial Material
Oncology
Clifford A. Hudis
JOURNAL OF CLINICAL ONCOLOGY
(2023)
Article
Hematology
Ashley Aaroe, Razelle Kurzrock, Gaurav Goyal, Aaron M. Goodman, Harsh Patel, Gordon Ruan, Gary Ulaner, Jason Young, Ziyi Li, Derek Dustin, Ronald S. Go, Eli L. Diamond, Filip Janku
Summary: ECD and RDD are rare non-LCHs with limited therapeutic options. The activation of the MAPK pathway through BRAFV600E mutation or other genomic alterations is a characteristic of histiocytosis and shows a positive response to BRAF inhibitors and the MEK inhibitor cobimetinib. This study retrospectively analyzed the outcomes of 26 adult patients treated with orally administered trametinib and found that the drug was effective in managing the diseases at low doses. The response rate was 71% in evaluable patients, including those without the detectable BRAFV600E mutation.
Letter
Clinical Neurology
J. Ivanidze, A. S. Nordvig, A. R. Fajardo, A. J. Tsiouris, G. C. -Y. Chiang, J. R. Osborne
AMERICAN JOURNAL OF NEURORADIOLOGY
(2023)
Article
Oncology
Jennifer A. Ligibel, Luke Huebner, Hope S. Rugo, Harold J. Burstein, Debra L. Toppmeyer, Carey K. Anders, Cynthia Ma, William T. Barry, Vera Suman, Lisa A. Carey, Ann H. Partridge, Clifford A. Hudis, Eric P. Winer
Summary: In metastatic breast cancer patients, high rates of obesity and inactivity were observed, but they were not significantly associated with PFS and OS. Greater than 9 MET hours of PA per week may be marginally associated with improved PFS and OS outcomes.
JNCI CANCER SPECTRUM
(2021)
Meeting Abstract
Oncology
Cynthia X. Ma, Vera Suman, A. Marilyn Leitch, Souzan Sanati, Kiran Vij, Gary W. Unzeitig, Jeremy Hoog, Mark Watson, Olwen Hahn, Joseph Guenther, Abigail Caudle, Erika Crouch, Horacio Maluf, Amy Tiersten, Monica Mita, Wajeeha Razaq, Tina J. Hieken, Yang Wang, Travis Dockter, Jo Anne Zujewski, Anna Weiss, Kelly Hunt, Clifford Hudis, Eric P. Winer, Matthew J. Ellis, Lisa A. Carey, Ann H. Partridge
Meeting Abstract
Oncology
Matthew J. Ellis, Vera Suman, A. Marilyn Leitch, Souzan Sanati, Kiran Vij, Gary W. Unzeitig, Jeremy Hoog, Mark Watson, Olwen Hahn, Joseph Guenther, Abigail Caudle, Erika Crouch, Horacio Maluf, Mitch Dowsett, Amy Tiersten, Monica Mita, Wajeeha Razaq, Tina J. Hieken, Yang Wang, Travis Dockter, Jo Anne Zujewski, Anna Weiss, Clifford Hudis, Eric P. Winer, Kelly Hunt, Ann H. Partridge, Cynthia X. Ma, Lisa A. Carey
Review
Oncology
Maria A. Mitry, Julie Sogani, Elizabeth J. Sutton, Priyadarshini Kumar, Steven Horwitz, Azadeh Elmi, Sejal N. Patel, Katherine Gallagher, Brittany Z. Dashevsky, Victoria Mango
JOURNAL OF BREAST IMAGING
(2020)
Article
Oncology
Alyssa A. Schatz, Thomas K. Oliver, Robert A. Swarm, Judith A. Paice, Deepika S. Darbari, Deborah Dowell, Salimah H. Meghani, Katy Winckworth-Prejsnar, Eduardo Bruera, Robert M. Plovnick, Lisa Richardson, Neha Vapiwala, Dana Wollins, Clifford A. Hudis, Robert W. Carlson
JCO ONCOLOGY PRACTICE
(2020)